The current status of trademark application 6144209 for STANCARE PHARMA is Objected.
The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.
| Application Number | 6144209 |
| Trademark Status | Objected |
| Trademark Class | 35 |
| Application Date | 2023-10-11 |
| Proprietor Name | MOUPIYAL CHATTERJEE |
| Appropriate Office | KOLKATA |
| State | BIHAR |
| Trademark Type | DEVICE |
| User Details | Proposed to be used |
| Agent Name | NEWTON REGINALD[25853] |
| Agent Address | No 6, Dhanammal Street Spurtank Road Chetpet Chennai - 600031 |
| Goods And Services Details | [CLASS : 35] Retail services provided by pharmacies, Advertising services relating to pharmaceuticals, Sales agency services featuring pharmaceutical preparations, Providing marketing leads for the pharmaceutical industry, Retail or wholesale services for pharmaceutical preparations, Providing administrative assistance to pharmacies for managing drug inventories, Business administration of pharmacy reimbursement programs and services, Wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies, Retail and wholesale services for diagnostic pharmaceutical products and diagnostic substances for medical use, Advertising services relating to pharmaceuticals for the treatment of diabetes, Business consultation services in the field of pharmaceutical leads |
Similar trademarks found for this brand
| Brand | Class | Status |
|---|---|---|
| STANCARE PHARMA | 35 | Objected |
Common questions about STANCARE PHARMA.